Urokinase-type plasminogen activator to prevent haze after photorefractive keratectomy, and pregnancy as a risk factor for haze in rabbits

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 5, 2004, Pages 1329-1333

  Csutak, Adrienne ^a   Silver, David M ^a,b   Tözsér, József ^a   Hassan, Ziad ^a   Berta, András ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; CORTICOSTEROID; UROKINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA OPACITY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HAZE; NONHUMAN; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; RABBIT; RISK FACTOR; SPECTROPHOTOMETRY; SUPEPITHELIAL HAZE; ANIMAL; METABOLISM; PREGNANCY COMPLICATION;

ANIMALS; APROTININ; CORNEAL OPACITY; FEMALE; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; RABBITS; RISK FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 2442668077     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0881     Document Type: Article

References (47)

1. Katlun T, Wiegand W. Haze and regression after photorefractive keratectomy (PRK). Ophthalmologe. 2000;97:487-490.
2. Bohnke M, Thaer A, Schipper I. Confocal microscopy reveals persisting stromal changes after myopic photorefractive keratectomy in zero haze corneas. Br J Ophthalmol. 1998;82:1393-1400.
3. Fisher EM, Ginsberg NE, Scher KS, Hersh PS. Photorefractive keratectomy for myopia with a 15 Hz repetition rate, J Cataract Refract Surg. 2000;26:303-304.
4. Siganos DS, Katsanevaki VJ, Pallikaris IG. Correlation of subepithelial haze and refractive regression 1 month after photorefractive keratectomy for myopia. J Refract Surg. 1999;15:338-342.
5. Csutak A, Tözsér J, Békési L, Hassan Z, Berta A, Silver DM. Plasminogen activator activity in tears after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2000;41:3743-3747.
6. Tabbara KF, El-Sheikh HF, Sharara NA, Aabed B. Corneal haze among blue eyes and brown eyes after photorefractive keratectomy. Ophthalmology. 1999;106:2210-2215.
7. Hefetz LH, Domnitz Y, Haviv D, et al. Influence of patient age on refraction and corneal haze after photorefractive keratectomy. Br J Ophthalmol. 1997;81:637-638.
8. Møller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea. 1998;17:627-639.
9. Brunette I, Gresset J, Boivin JF, et al. Functional outcome and satisfaction after photorefractive keratectomy. Part 2: survey of 690 patients. Ophthalmology. 2000;107:1790-1796.
10. Thorig L, Wijngaards G, Van Haeringen NJ. Immunological characterization and possible origin of plasminogen activator in human tear fluid. Ophthalmic Res. 1983;15:268-276.
11. Hayashi K, Sueishi K. Fibrinolytic activity and species of plasminogen activator in human tears. Exp Eye Res. 1988;46:131-137.
12. Berta A, Tözsér J, Holly FJ. Determination of plasminogen activator activities in normal and pathological human tears: the significance of tear plasminogen activators in the inflammatory and traumatic lesions of the cornea and conjunctiva. Acta Ophthalmol (Copenh). 1990;68:508-514.
13. Tripathi RC, Tripathi BJ, Park JK. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp Eye Res. 1990;51:545-552.
14. Lohmann CP, Marshall J. Plasmin- and plasminogen-activator inhibitors after excimer laser photorefractive keratectomy: new concept in prevention of postoperative myopic regression and haze. Refract Corneal Surg. 1993;9:300-302.
15. Barlati S, Marchina E, Quaranta CA, et al. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Exp Eye Res. 1990;51:1-9.
16. O'Brart DPS, Lohmann CP, Klonos G, et al. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy. Ophthalmology. 1994;101:1565-1574.
17. Csutak A, Silver DM, Tözsér J, Facskó A, Berta A. Plasminogen activator activity and inhibition in rabbit tears after photorefractive keratectomy. Exp Eye Res. 2003;77:675-680.
18. Kruithof EK, Tran-Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood. 1987;69:460-466.
19. Wright JG, Cooper P, Astedt B, et al. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol. 1988;69:253-258.
20. Walker JE, Gow L, Campbell DM, Ogston D. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost. 1983;49:21-23.
21. Tözsér J, Berta A, Punyiczki M. Plasminogen activator activity and plasminogen independent amidolytic activity in tear fluid from healthy persons and patients with anterior segment inflammation. Clin Chim Acta. 1989;183:323-331.
22. van Haeringen NJ, Glasius E. The origin of some enzymes in tear fluid, determined by comparative investigations with two collection methods. Exp Eye Res. 1976;22:267-272.
23. Shimada H, Mori T, Takada A, et al. Use of chromogenic substrate S-2251 for determination of plasminogen activator in rat ovaries. Thromb Haemost (Stuttgart). 1981;46:507-510.
24. Tözsér J, Berta A. Urokinase-type plasminogen activator in rabbit tears: comparison with human tears. Exp Eye Res. 1990;51:33-37.
25. Hanna KD, Pouliquen YM, Savoldelli M, et al. Corneal wound healing in monkeys 18 months after excimer laser photorefractive keratectomy. Refract Corneal Surg. 1990;6:340-345.
26. Bland M. An Introduction to Medical Statistics. (2nd ed). Oxford, UK: Oxford University Press; 1995.
27. Van Setten GB, Salonen EM, Vaheri A, et al. Plasmin and plasminogen activator activities in tear fluid during corneal wound healing after anterior keratectomy. Curr Eye Res. 1989;8:1293-1298.
28. Vinciguerra P, Azzolini M, Radice P, Sborgia M, De Molfetta V. A method for examining surface and interface irregularities after photorefractive keratectomy and laser in situ keratomileusis: predictor of optical and functional outcomes. J Refract Surg. 1998;14:S204-S206.
29. McDonald MB, Steinert RF, Bafna S. Laboratory and clinical studies of excimer laser refractive surgery. In: Wu HK, Thompson VM, Steinert RF, Hersh PS, Slade SG, eds. Refractive Surgery. New York: Thieme; 1999:225-246.
30. Chang JH, Kook MC, Lee JH, Chung H, Wee WR. Effects of synthetic inhibitor of metalloproteinase and cyclosporin A on corneal haze after excimer laser photorefractive keratectomy in rabbits. Exp Eye Res. 1998;66:389-396.
31. Wong TT, Mead AL, Khaw PT. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtering surgery. Invest Ophthalmol Vis Sci. 2003;44:1097-1103.
32. Kaji Y, Amano S, Oshika T, et al. Effect of anti-inflammatory agents on corneal wound-healing process after surface excimer laser keratectomy. J Cataract Refract Surg. 2000;26:426-431.
33. Talamo JH, Gollamundi S, Green WR, DeLaCruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 1991;109:1141-1146.
34. Xu H, Liu S, Xia X, Huang P, Wang P, Wu X. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg. 2001;17:342-349.
35. Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg. 2002;28:2088-2095.
36. 1 in tears following laser subepithelial keratomileusis and photorefractive keratectomy. J Refract Surg. 2002;18:130-134.
37. 1 after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg. 2001;27:1840-1846.
38. Faktorovich EG, Badawi DY, Maloney RK, Ariyasu RG. Growth factor expression in corneal wound healing after excimer laser keratectomy. Cornea. 1999;18:580-588.
39. Chen C, Michelini-Norris B, Stevens S, et al. Measurement of mRNAs for TGFβ and extracellular matrix proteins in corneas of rats after PRK. Invest Ophthalmol Vis Sci. 2000;41:4108-4116.
40. Morlet N, Gillies MC, Crouch R, Maloof A. Effect of topical interferon-α 2b on corneal haze after excimer laser photorefractive keratectomy in rabbits. Refract Corneal Surg. 1993;9:443-451.
41. Gillies MC, Garrett SK, Shina SM, Morlet N, Taylor HR. Topical interferon α 2b for corneal haze after excimer laser photorefractive keratectomy. J Cataract Refract Surg. 1996;22:891-900.
42. Bilgihan K, Ozdek S, Ozogul C, Gurelik G, Bilgihan A, Hasanreisoglu B. Topical vitamin E and hydrocortisone acetate treatment after photorefractive keratectomy. Eye. 2000;14:231-237.
43. Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci. 1980;19:1204-1221.
44. Berta A, Holly FJ, Tözsér J, Holly TF. Tear plasminogen activators: indicators of epithelial cell destruction-the effect of scraping, n-heptanol debridement, and alkali bum of the cornea on the plasminogen activator activity of rabbit tears. Int Ophthalmol. 1991;15:363-369.
45. Berman MB. Regulation of corneal fibroblast MMP-1 collagenase secretion by plasmin. Cornea. 1993;12:420-432.
46. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981;41:4629-4636.
47. Hull DS, Green K. Effect of urokinase on corneal endothelium. Arch Ophthalmol. 1980;98:1285-1286.